VIGNOZZI, LINDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.251
EU - Europa 9.618
AS - Asia 3.719
SA - Sud America 471
OC - Oceania 173
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 1
Totale 29.330
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.179
RU - Federazione Russa 3.525
IT - Italia 1.976
HK - Hong Kong 1.395
PL - Polonia 1.342
SG - Singapore 1.060
IE - Irlanda 856
SE - Svezia 635
CN - Cina 555
BR - Brasile 422
DE - Germania 233
FI - Finlandia 205
IN - India 191
CH - Svizzera 173
AU - Australia 172
GB - Regno Unito 154
JO - Giordania 123
UA - Ucraina 123
FR - Francia 108
NL - Olanda 105
ID - Indonesia 96
VN - Vietnam 67
CA - Canada 61
TR - Turchia 61
CI - Costa d'Avorio 53
AT - Austria 49
ES - Italia 38
JP - Giappone 36
KR - Corea 21
BE - Belgio 19
AR - Argentina 17
RO - Romania 16
ZA - Sudafrica 16
LT - Lituania 14
BD - Bangladesh 11
IR - Iran 11
PH - Filippine 10
IQ - Iraq 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
AZ - Azerbaigian 8
MX - Messico 8
EC - Ecuador 7
MA - Marocco 7
SC - Seychelles 7
TW - Taiwan 7
AL - Albania 6
MD - Moldavia 6
PK - Pakistan 6
CZ - Repubblica Ceca 5
GR - Grecia 5
PE - Perù 5
BO - Bolivia 4
CL - Cile 4
CO - Colombia 4
HR - Croazia 4
IL - Israele 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
PT - Portogallo 4
SA - Arabia Saudita 4
VE - Venezuela 4
DZ - Algeria 3
EE - Estonia 3
MU - Mauritius 3
PY - Paraguay 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
KE - Kenya 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MK - Macedonia 2
NG - Nigeria 2
NP - Nepal 2
TM - Turkmenistan 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 29.329
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.734
Fairfield 1.736
Warsaw 1.334
Hong Kong 1.170
Ashburn 1.030
Chandler 925
Dublin 852
Woodbridge 799
Seattle 750
Houston 730
Cambridge 638
Singapore 582
Wilmington 568
Altamura 369
Lawrence 366
Florence 314
Ann Arbor 255
Princeton 244
Moscow 223
Jacksonville 210
Melbourne 164
Bern 158
Boston 145
Beijing 138
Mumbai 136
San Diego 130
Rome 128
Buffalo 121
Medford 112
Milan 112
Boardman 106
Shanghai 101
Jakarta 94
Paris 75
New York 72
Falls Church 62
Kent 56
Los Angeles 55
Abidjan 53
Helsinki 53
The Dalles 52
Dong Ket 46
Redwood City 43
Vienna 39
Norwalk 36
London 35
Hillsboro 32
Lappeenranta 30
Okayama 30
Bologna 29
Munich 29
West Jordan 29
Izmir 28
Barcelona 26
Naples 26
São Paulo 26
Dearborn 24
Yubileyny 24
Toronto 23
Pune 22
Andover 21
Belo Horizonte 20
Guangzhou 20
Brussels 18
Turin 18
Rio de Janeiro 15
Detroit 14
Salerno 14
Ottawa 13
Palermo 13
Shenzhen 13
Chennai 12
North Bergen 12
Redmond 12
Verona 12
Falkenstein 11
Zurich 11
Seoul 10
Villanova Mondovì 10
Amsterdam 9
Bremen 9
Düsseldorf 9
Las Vegas 9
Tashkent 9
Trieste 9
Auburn Hills 8
Baku 8
Calgary 8
Frankfurt am Main 8
Hangzhou 8
Ho Chi Minh City 8
Istanbul 8
Messina 8
Ankara 7
Bari 7
Barnet 7
Chicago 7
Fortaleza 7
Haarlem 7
Laurel 7
Totale 19.965
Salva come PNG Salva come JPEG
Nome #
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 485
THE USE OF TADALAFIL TO TREAT LOWER URINARY TRACT SYMPTOMS AND ERECTILE DYSFUNCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW 260
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation 256
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. 250
Negative Effects of High Glucose Exposure in Human Gonadotropin-Releasing Hormone Neurons 245
Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlates with Sexual Dysfunctions 244
Global Consensus Position Statement on the Use of Testosterone Therapy for Women 233
Insulino-resistenza e fertilità nella donna con attenzione a sindrome dell'ovaio policistico (PCOS) e malattia epatica non alcoolica (NAFLD) 230
Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial. 218
Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study. 218
Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study 218
Androgens regulate Phosphodiesterase type 5 expression and functional activity in corpora cavernosa 200
Meta-analysis of metabolic syndrome and prostate cancer 193
INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function 191
Tumor Necrosis Factor α Impairs Kisspeptin Signaling in Human Gonadotropin-Releasing Hormone Primary Neurons 188
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. 186
Acute effects on human sperm exposed in vitro to cadmium chloride and diisoutyl-phthalate 174
Cardiometabolic Risk and Female Sexuality: Focus on Clitoral Vascular Resistance 170
Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats 167
The non-aromatizable androgen dihydrotestosterone (DHT) facilitates sexual behavior in ovariectomized female rats primed with estradiol. 165
Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men 164
Role of Androgens in Female Genitourinary Tissue Structure and Function: Implications in the Genitourinary Syndrome of Menopause. 163
Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats. 161
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. 161
Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension. 158
The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery 155
Brain Sex Differences Related to Gender Identity Development: Genes or Hormones? 155
A Randomized, Placebo-Controlled Study to Assess Safety andEfficacy of Vardenafil 10 mg and Tamsulosin 0.4 mg vs. Tamsulosin 0.4 mg Alone in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. 155
Insight on the intracrinology of menopause: androgen production within the human vagina 155
Psychosexual Correlates of Unwanted Sexual Experiences in Women Consulting for Female Sexual Dysfunction According to Their Timing Across the Life Span 153
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. 153
5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature 148
Anti-inflammatory effects of androgens in the human vagina 148
Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis. 146
Identification, characterization and biological activity of oxytocin receptor in the developing human penis. 145
Role of Sexuality in the Outcome of Anorexia Nervosa and Bulimia Nervosa: A 3-Year Follow-Up Study 145
Anti-inflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. 145
Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data 145
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. 144
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis 144
Neural Correlates of Gender Face Perception in Transgender People 143
Back to the Future: Is GnRHa treatment in transgender and gender diverse adolescents only an extended evaluation phase? 143
Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study. 141
Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. 140
Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER? 140
Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries: a prospective, exploratory study 140
Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. 139
Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis. 138
Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. 138
Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits. 137
Clinical characteristics of men complaining of premature ejaculation together with erectile dysfunction: a cross-sectional study. 136
PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH 136
METABOLIC SYNDROME-ASSOCIATED SPERM ALTERATIONS IN AN EXPERIMENTAL RABBIT MODEL: RELATION WITH METABOLIC PROFILE, TESTIS AND EPIDIDYMIS GENE EXPRESSION AND EFFECT OF TAMOXIFEN TREATMENT 136
CHILDHOOD SEXUAL ABUSE MODERATES THE RELATIONSHIP BETWEEN SEXUAL FUNCTIONING AND EATING DISORDER PSYCHOPATHOLOGY IN ANOREXIA NERVOSA AND BULIMIA NERVOSA: A 1-YEAR-FOLLOW-UP STUDY. 135
Benign prostatic hyperplasia: a new metabolic disease? 135
Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction 135
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia? 133
Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway. 132
BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder. 132
Obesity and hormonal contraception: an overview and a clinician's practical guide 132
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. 131
Treatment of Functional Hypogonadism Besides Pharmacological Substitution 131
Characterization and functional role of androgen-dependent PDE5 activity in the bladder. 130
Testosterone, cardiovascular disease and the metabolic syndrome. 130
Anorectic and Bulimic Patients Suffer from Relevant Sexual Dysfunctions. 130
LH supplementation of ovarian stimulation protocols influences follicular fluid steroid composition contributing to the improvement of ovarian response in poor responder women. 129
Metabolic syndrome and prostate abnormalities in male subjects of infertile couples 128
Klinefelter syndrome: cardiovascular abnormalities and metabolic disorders. 128
Klinefelter's Syndrome: A Clinical and Therapeutical Update 128
A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. 127
Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. 127
Outcome of Medical and Psychosexual Interventions for Vaginismus: A Systematic Review and Meta-Analysis. 127
Low Testosterone Levels Predict Clinical Adverse Outcomes in SARS-CoV-2 Pneumonia Patients 127
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. 126
Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. 126
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial 126
Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound. 126
Beneficial effects of bile acid receptor agonists in pulmonary disease models. 126
Testosterone protects from metabolic syndrome-associated prostate inflammation: An experimental study in rabbit 126
Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model. 125
Hypogonadotropic hypogonadism and metabolic syndrome: insights from the high-fat diet experimental rabbit animal model 124
Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model 123
Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes. 122
Risks and benefits of late onset hypogonadism treatment: an expert opinion 121
Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit. 121
The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder 120
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. 120
Peripheral regulatory mechanisms in erection 120
Validation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: The Orgasmometer-F 119
Sexual Health in Menopause 119
Psychobiological Correlates of Vaginismus: An Exploratory Analysis 119
Reply: COVID-19: Semen impairment may not be related to the virus 118
Human prostatic urethra expresses Vitamin D receptor and responds to Vitamin D receptor ligation. 118
Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. 117
Sex Steroid Receptors in Male Human Bladder: Expression and Biological Function. 117
Male reproductive system inflammation after healing from coronavirus disease 2019 116
Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model. 115
Which are the male factors associated with female sexual dysfunction (FSD)? 115
Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI) 115
Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility 114
Totale 15.202
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.148
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020406 0 0 0 0 0 0 0 0 0 0 315 91
2020/20212.598 197 221 134 418 127 257 139 184 246 354 163 158
2021/20222.029 85 205 301 61 55 77 74 235 96 82 316 442
2022/20234.444 387 995 168 268 290 711 523 224 392 131 122 233
2023/20242.636 72 178 366 132 202 237 181 642 103 245 181 97
2024/202512.275 511 1.320 891 2.008 3.580 1.393 417 791 709 481 174 0
Totale 30.049